Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6 -174 G/C promoter polymorphism and effects of fenofibrate and simvastatin on inflammatory markers in hypercholesterolemic patients.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jan 2006

Potaczek Daniel P, Undas Anetta, Celinska-Lowenhoff Magdalena, Szczeklik Andrew

Abstract excerpt

To evaluate whether the interleukin-6 (IL-6) -174 G/C polymorphism might alter the effects of micronized fenofibrate or simvastatin therapy on inflammatory markers, we measured IL-6, C-reactive protein, CD40 ligand, adhesion molecules, P-selectin and monocyte chemoattractant protein-1 in hypercholesterolemic patients both before and after a 30-day treatment. Serum IL-6 levels were significantly higher in patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to C-Reactive Protein
Share to CD40 Ligand

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypercholesterolemia

Share to Hypolipidemic Agents

Share to Interleukin-6

Share to P-Selectin

Share to Simvastatin

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 16607077
DOI: 10.1097/01.mbc.0000198052.65505.00

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6 -174 G/C promoter polymorphism and effects of fenofibrate and simvastatin on inflammatory markers in hypercholesterolemic patients.PMID 16607077Read ↗

Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.Semantic proximity Read ↗

Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.Semantic proximity Read ↗

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.Semantic proximity Read ↗

Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.Semantic proximity Read ↗

Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.Semantic proximity Read ↗

IL-6 gene promoter polymorphisms and risk of coronary artery disease in a Chinese population.Semantic proximity Read ↗

Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women.Semantic proximity Read ↗

Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects.Semantic proximity Read ↗

The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers.Semantic proximity Read ↗

Association between the -174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women.Semantic proximity Read ↗

Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS)Semantic proximity Read ↗

Interleukin 6 promoter polymorphisms in normal Han Chinese population: frequencies and effects on inflammatory markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.